{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:55:31Z","timestamp":1791543331308,"version":"4.3.4"},"reference-count":31,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Genetic Testing and Molecular Biomarkers"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Prostate cancer (PCa) is genetically a complicated disease with mediation by variations in genes coding for androgen biosynthesis and signaling genes. In the current study, we investigate the associations of key polymorphisms in the androgen pathway with serum testosterone and prostate-specific antigen (PSA) levels, while also exploring their potential functional impact using bioinformatics analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A total of 314 patients with prostate adenocarcinoma and 287 age-matched healthy controls were genotyped for ten SNPs across CYP17A1, HSD3B1, HSD3B2, SRD5A2, and AR genes using sequencing methods. Associations with disease risk, serum testosterone, and PSA were evaluated. Functional predictions, linkage disequilibrium (LD), and protein\u2013protein interaction (PPI) network analyses were performed\n                      <jats:italic toggle=\"yes\">in silico<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Significant associations were found for CYP17A1 (rs10883783), HSD3B1 (rs6203, rs33937873), SRD5A2 (rs12470143) with PCa risk, whereas androgen receptors polymorphisms (rs1204038, rs6152) and HSD3B2 (rs1819698, rs58154933) showed no association. The A allele of CYP17A1 rs10883783 and the T allele of HSD3B1 rs6203 were correlated with lower testosterone levels, while only the CYP17A1 rs10883783 polymorphism was significantly associated with increased PSA levels. Bioinformatic analysis showed potential deleterious effects for the HSD3B1 rs6203 variant, as well as regulatory effects for CYP17A1 rs10883783, in accordance with their corresponding enzymatic role in androgen biosynthesis. Additionally, analysis of PPI and co-expression networks revealed tight functional connectivity of the androgen pathway genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These results suggest a biological function for genetic polymorphisms of HSD3B1 and CYP17A1 in PCa susceptibility and androgen regulation. These polymorphic variants can serve as effective risk biomarkers for PCa and disease activity using a combination of genotyping, hormone assay, and bioinformatics. These findings need more research, including larger multi-ethnic cohorts and functional validation to ascertain their therapeutic relevance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/19450265261488655","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:19:27Z","timestamp":1789989567000},"page":"242-254","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative Genetic and Bioinformatic Analysis of Androgen Pathway Gene Polymorphisms, Testosterone, and PSA Levels in Prostate Cancer"],"prefix":"10.1177","volume":"30","author":[{"given":"Ghasem","family":"Ghorbani Vale Zaghard","sequence":"first","affiliation":[{"name":"Department of Biology, Ah.C., Islamic Azad University, Ahar, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8400-4209","authenticated-orcid":false,"given":"Mehdi","family":"Haghi","sequence":"additional","affiliation":[{"name":"Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Ghiamirad","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Ah.C., Islamic Azad University, Ahar, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Ghorbian","sequence":"additional","affiliation":[{"name":"Department of Biology, Ta.C., Islamic Azad University, Tabriz, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Ebrahimi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Biophysics, VaP.C., Islamic Azad University, Varamin, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2022.12787"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.652747"},{"issue":"2","key":"e_1_3_3_4_1","first-page":"62","article-title":"Androgen action in prostate function and disease","volume":"6","author":"Banerjee PP","year":"2018","unstructured":"Banerjee PP, , Banerjee S, , Brown TR, , Zirkin BR. Androgen action in prostate function and disease. Am J Clin Exp Urol 2018;6(2):62\u201377.","journal-title":"Am J Clin Exp Urol"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-09-0076"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-10-0339"},{"issue":"6","key":"e_1_3_3_7_1","first-page":"1784","article-title":"Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility","volume":"62","author":"Chang B-L","year":"2002","unstructured":"Chang B-L, , Zheng SL, , Hawkins GA, et al. Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility. Cancer Res 2002;62(6):1784\u20131789.","journal-title":"Cancer Res"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.10358"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2018.01.005"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0767"},{"issue":"4","key":"e_1_3_3_11_1","first-page":"775","article-title":"Pharmacologic interruption of the mitogen-activated extracellular-regulated kinase\/mitogen-activated protein kinase signal transduction pathway: Potential role in promotingcytotoxic drug action","volume":"7","author":"Dent P","year":"2001","unstructured":"Dent P, , Grant S. Pharmacologic interruption of the mitogen-activated extracellular-regulated kinase\/mitogen-activated protein kinase signal transduction pathway: Potential role in promotingcytotoxic drug action. Clin Cancer Res 2001;7(4):775\u2013783.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24031873"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2021.111239"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2014.229476"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.01.003"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194771"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2013.16"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.4137\/CIN.S12128"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-016-1771-2"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2017.168"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.150403"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1100"},{"issue":"5","key":"e_1_3_3_23_1","first-page":"1873","article-title":"Gene polymorphism-related differences in the outcomes of abiraterone for prostate cancer: A systematic overview","volume":"11","author":"Liu M","year":"2021","unstructured":"Liu M, , Shi H, , Yan J, et al. Gene polymorphism-related differences in the outcomes of abiraterone for prostate cancer: A systematic overview. Am J Cancer Res 2021;11(5):1873.","journal-title":"Am J Cancer Res"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.11.076"},{"issue":"3","key":"e_1_3_3_25_1","first-page":"212","article-title":"Steroid hormone synthetic pathways in prostate cancer","volume":"2","author":"Mostaghel EA","year":"2013","unstructured":"Mostaghel EA. Steroid hormone synthetic pathways in prostate cancer. Transl Androl Urol 2013;2(3):212\u2013227.","journal-title":"Transl Androl Urol"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31664"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30071"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2011.07.007"},{"key":"e_1_3_3_29_1","first-page":"239","volume-title":"Prostate Cancer: Cellular and Genetic Mechanisms of Disease Development and Progression","author":"Storbeck K-H","year":"2020","unstructured":"Storbeck K-H, , Mostaghel EA. \u201cCanonical and noncanonical androgen metabolism and activity.\u201d Prostate Cancer: Cellular and Genetic Mechanisms of Disease Development and Progression: 2020;239\u2013277."},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2016.221"},{"issue":"1","key":"e_1_3_3_31_1","article-title":"Expression of HSD3B1 and HSD3B2 genes in adenocarcinoma and benign prostatic hyperplasia","volume":"10","author":"Zaghard GGV","year":"2022","unstructured":"Zaghard GGV, , Haghi M, , Ghiamirad M, et al. Expression of HSD3B1 and HSD3B2 genes in adenocarcinoma and benign prostatic hyperplasia. Gene Cell Tissue 2022;10(1).","journal-title":"Gene Cell Tissue"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1530\/JME-14-0203"}],"container-title":["Genetic Testing and Molecular Biomarkers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19450265261488655","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/19450265261488655","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19450265261488655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:30:01Z","timestamp":1791541801000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/19450265261488655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"alternative-id":["10.1177\/19450265261488655"],"URL":"https:\/\/doi.org\/10.1177\/19450265261488655","relation":{},"ISSN":["1945-0265","1945-0257"],"issn-type":[{"value":"1945-0265","type":"print"},{"value":"1945-0257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}